Illkirch
France
27
2015-04-23
27
2016-03-29
These are the the leading inventors for applications assigned to Transgene S.A.:
Transgene S.A. based in Illkirch, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for producing poxviruses and poxvirus compositions
#2 | 2015-01-15 ✅ Patent 9,687,515 granted on 2017-06-27Poxviral oncolytic vectors
#3 | 2014-09-11 ✅ Patent 9,139,652 granted on 2015-09-22Method for increasing M1 macrophages in a patient
#4 | 2014-03-13 ✅ Patent 9,012,198 granted on 2015-04-21Method for orthopoxvirus production and purification
#5 | 2013-09-19 ✅ Patent 8,809,056 granted on 2014-08-19Immortalized avian cell lines comprising E1A nucleic acid sequences
#6 | 2013-09-12 ✅ Patent 8,778,675 granted on 2014-07-15Immortalized avian cell lines and use thereof
#7 | 2013-04-04 ✅ Patent 8,415,134 granted on 2013-04-09Process for producing poxviruses and poxvirus compositions
#8 | 2013-01-10 ✅ Patent 9,393,299 granted on 2016-07-19Composition for treating HBV infection
#9 | 2012-11-01 ✅ Patent 8,415,133 granted on 2013-04-09Process for producing poxviruses and poxvirus compositions
#10 | 2012-09-20 ✅ Patent 8,513,018 granted on 2013-08-20Immortalized avian cell lines
#11 | 2012-05-17 ✅ Patent 8,445,270 granted on 2013-05-21Immortalized avian cell lines and use thereof
#12 | 2012-04-19 ✅ Patent 8,945,581 granted on 2015-02-03Process for producing poxviruses and poxvirus compositions
#13 | 2012-03-08 ✅ Patent 8,609,392 granted on 2013-12-17Method for orthopoxvirus production and purification
#14 | 2012-02-16 ✅ Patent 8,541,004 granted on 2013-09-24Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#15 | 2011-09-01 ✅ Patent 8,445,270 granted on 2013-05-21IMMORTALIZED AVIAN CELL LINES AND USE THEREOF
#16 | 2011-03-10 ✅ Patent 8,778,328 granted on 2014-07-15Poxviral oncolytic vectors
#17 | 2011-02-24 ✅ Patent 9,180,150 granted on 2015-11-10Poxviral oncolytic vectors
#18 | 2011-01-13 ✅ Patent 8,357,531 granted on 2013-01-22Immortalized avian cell lines
#19 | 2010-12-30 ✅ Patent 8,257,692 granted on 2012-09-04Polypeptide having an improved cytosine deaminase activity
#20 | 2010-12-30 ✅ Patent 8,226,954 granted on 2012-07-24Polypeptide having an improved cytosine deaminase activity
#21 | 2010-12-16 ✅ Patent 8,211,421 granted on 2012-07-03Mutant having uracil phosphoribosyl transferase activity
#22 | 2010-12-02 ✅ Patent 8,337,859 granted on 2012-12-25Vectors for multiple gene expression
#23 | 2010-08-05 ✅ Patent 8,361,788 granted on 2013-01-29Immortalized avian cell lines comprising E1A nucleic acid sequences
#24 | 2010-07-08 ✅ Patent 9,024,003 granted on 2015-05-05Avian telomerase reverse transcriptase
#25 | 2010-06-24 ✅ Patent 8,415,462 granted on 2013-04-09Signaling peptides
#26 | 2010-06-10 ✅ Patent 8,420,103 granted on 2013-04-16Papillomavirus vaccines
#27 | 2009-07-02 ✅ Patent 8,470,591 granted on 2013-06-25Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
453852 ⎘